HealthcareEmergent stock jumps as FDA clears smallpox vaccine for people at high risk of mpoxBy Helitra.com·August 31, 2024·1 min read Emergent stock jumps as FDA clears smallpox vaccine for people at high risk of mpox Source: SeekingalphaADVERTISEMENT ADVERTISEMENTclears Emergent FDA high jumps mpox people risk smallpox stock vaccine Post navigation Previous storyAlnylam falls after full data for heart drug that can rival Pfizer’sNext storyEkso Bionics prices $6M offering
Fitness · HealthcareWhich Age Group Is Happiest Taking a GLP-1 Drug?October 27, 2026Key Takeaways GLP-1 medication use is more common among younger generations (Gen Z) than older generations (baby boomers). Millennials are more likely than…
Fitness · HealthcareAre GLP-1 Users Satisfied With Their Weight Loss?October 27, 2026Key Takeaways Among current and past GLP-1 users, 70 percent of those surveyed were satisfied with their weight loss. But the number dropped…
Fitness · HealthcareThree One-Minute Bursts of Movement Daily Linked to Lower MortalityOctober 27, 2026Picture a committed lifter. Four hard sessions a week, solid numbers, takes training seriously. Then the other 23 hours of the day: a…